Open-label placebos and test anxiety. A randomized controlled study.

Open-label placebos and test anxiety. A randomized controlled study. - CoEha

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013621

Enrollment

Registered

2018-01-30

Start date

2018-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Test anxiety

Interventions

Group 1: The intervention group receives two weeks before an academic test an open-label placebo (2 each day) Group 2: control group (no placebos)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Students at an university who have to pass an exam (oral or written)

Exclusion criteria

Exclusion criteria: Diabetes, known psychiatric or neurologic deseases

Design outcomes

Primary

Measure	Time frame
Shortly before the academic test test anxiety will be assessed by using psychological questionnaires.	—

Secondary

Measure	Time frame
Grade in test	—

Countries

Germany

Contacts

Public ContactMichael Schaefer

Medical School Berlin

michael.schaefer@medicalschool-berlin.de0306117542

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026